Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06021756 |
|
Recruitment Status :
Active, not recruiting
First Posted : September 1, 2023
Last Update Posted : September 1, 2023
|
Sponsor:
University of Arizona
Collaborator:
Scott Richards
Information provided by (Responsible Party):
Scott Sherman, University of Arizona
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | August 25, 2022 |
| Estimated Study Completion Date : | August 25, 2023 |